Fresenius Medical Care AG (FMS) Income towards Parent Company (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported Income towards Parent Company for 17 consecutive years, with $380.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Income towards Parent Company rose 431.65% year-over-year to $380.6 million; the TTM figure through Dec 2025 stood at $1.1 billion (up 91.02% YoY), while the FY2025 annual figure was $1.1 billion, up 98.02% from the prior year.
• Income towards Parent Company came in at $380.6 million for Q4 2025 at Fresenius Medical Care AG, up from $321.3 million in the prior quarter.
• The five-year high for Income towards Parent Company was $391.5 million in Q3 2021, with the low at $71.6 million in Q4 2024.
• Average Income towards Parent Company over 5 years is $231.8 million, with a median of $235.8 million recorded in 2022.
• Across the five-year window, Income towards Parent Company plunged 67.95% in 2023 and jumped 431.65% in 2025, its largest moves.
• Year by year, Income towards Parent Company stood at $300.9 million in 2021, then retreated by 14.21% to $258.1 million in 2022, then decreased by 21.64% to $202.3 million in 2023, then tumbled by 64.6% to $71.6 million in 2024, then surged by 431.65% to $380.6 million in 2025.
• According to Business Quant data, Income towards Parent Company over the past three periods registered $380.6 million, $321.3 million, and $254.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.